Technological and methodological innovations are equipping researchers with unprecedented
capabilities for detecting and characterizing pathologic processes in the developing …

Background COMP360 is a proprietary, synthetic formulation of psilocybin being developed
for treatment-resistant depression (TRD), a burdensome, life-threatening illness with high …

… I thank Abigail Septimus for assisting me with some of the charts and figures; and Richard
… Batya Ungar-Sargon's positive feedback and close reading of my work encouraged me to …

New York City above all other cities is in a perpetual state of growth. Its buildings scrape the
skies and crowd the blue yonder; its transportation occupies the subterranean. There are …

Elijah ben Solomon, the" Genius of Vilna,” was perhaps the best-known and most understudied
figure in modern Jewish history. This book offers a new narrative of Jewish modernity …

Background Psilocybin is being studied for use in treatment-resistant depression. Methods
In this phase 2 double-blind trial, we randomly assigned adults with treatment-resistant …

… Batya Septimus for their comments and contributions to the editing of this paper; and Jon
Kilner for his editing services. We are particularly grateful to the team at King's College London, …

Psilocybin is being investigated as a treatment in adults with treatment-resistant depression (TRD).
Withdrawal from serotonergic antidepressant drugs is a common prerequisite for …

… However, my wife Batya's contribution to this dissertation was … Batya gave me the help I
needed to overcome this hurdle … Batya energetically appl I_ S Cl ilG jT considerable scholarly …

Background The Healthy Brain Network is an openly shared pediatric psychiatric biobank
with a target of 10,000 participants between the ages of 5 and 21, inclusively In adding …